Zhejiang Hengtong Holding Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE0000010Q7
CNY
5.65
-0.08 (-1.4%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor long term growth as Net Sales has grown by an annual rate of 22.59% and Operating profit at 11.94% over the last 5 years

 
2

Negative results in Sep 25

3

With ROE of 5.82%, it has a attractive valuation with a 3.65 Price to Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 18,878 Million (Large Cap)

stock-summary
P/E

63.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.09

stock-summary
Return on Equity

5.60%

stock-summary
Price to Book

5.22

Revenue and Profits:
Net Sales:
697 Million
(Quarterly Results - Mar 2026)
Net Profit:
72 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.2%
0%
-5.2%
6 Months
33.57%
0%
33.57%
1 Year
94.83%
0%
94.83%
2 Years
126.91%
0%
126.91%
3 Years
113.21%
0%
113.21%
4 Years
160.37%
0%
160.37%
5 Years
94.83%
0%
94.83%

Zhejiang Hengtong Holding Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
22.59%
EBIT Growth (5y)
11.94%
EBIT to Interest (avg)
-50.31
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.03
Sales to Capital Employed (avg)
0.27
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.13%
ROE (avg)
7.93%

Valuation key factors

Factor
Value
P/E Ratio
63
Industry P/E
Price to Book Value
3.65
EV to EBIT
-217.27
EV to EBITDA
154.35
EV to Capital Employed
3.52
EV to Sales
8.33
PEG Ratio
4.21
Dividend Yield
NA
ROCE (Latest)
-1.62%
ROE (Latest)
5.82%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 18.47% vs 32.55% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 483.74% vs -80.06% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "696.60",
          "val2": "588.00",
          "chgp": "18.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-11.70",
          "val2": "10.80",
          "chgp": "-208.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "9.10",
          "val2": "0.50",
          "chgp": "1,720.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "14.90",
          "val2": "25.10",
          "chgp": "-40.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "71.80",
          "val2": "12.30",
          "chgp": "483.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-16.80%",
          "val2": "-41.40%",
          "chgp": "2.46%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 39.51% vs 105.22% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 21.32% vs 8.09% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,849.80",
          "val2": "1,325.90",
          "chgp": "39.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "101.60",
          "val2": "88.60",
          "chgp": "14.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "22.20",
          "val2": "23.20",
          "chgp": "-4.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "34.30",
          "val2": "-23.90",
          "chgp": "243.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "200.90",
          "val2": "165.60",
          "chgp": "21.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-14.00%",
          "val2": "-13.00%",
          "chgp": "-0.10%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQstock-summary

Mar'26
Dec'25
Change(%)
Net Sales
696.60
588.00
18.47%
Operating Profit (PBDIT) excl Other Income
-11.70
10.80
-208.33%
Interest
9.10
0.50
1,720.00%
Exceptional Items
14.90
25.10
-40.64%
Consolidate Net Profit
71.80
12.30
483.74%
Operating Profit Margin (Excl OI)
-16.80%
-41.40%
2.46%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2026 is 18.47% vs 32.55% in Dec 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 483.74% vs -80.06% in Dec 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
1,849.80
1,325.90
39.51%
Operating Profit (PBDIT) excl Other Income
101.60
88.60
14.67%
Interest
22.20
23.20
-4.31%
Exceptional Items
34.30
-23.90
243.51%
Consolidate Net Profit
200.90
165.60
21.32%
Operating Profit Margin (Excl OI)
-14.00%
-13.00%
-0.10%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 39.51% vs 105.22% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 21.32% vs 8.09% in Dec 2024

stock-summaryCompany CV
About Zhejiang Hengtong Holding Co., Ltd. stock-summary
stock-summary
Zhejiang Hengtong Holding Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available